Healncure Products Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 M
- Revenue Growth 210.85%
- Profit Growth 53.74%
- Ebitda 88.31%
- Net Worth 58.55%
- Total Assets 96.82%
About Healncure Products
Healncure Products Private Limited (HPPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 July 2019 (Five years and seven months 9 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.00 M.
Varsha Jain and Megha Jain serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U51909DL2019PTC352084
-
Company No.
352084
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Jul 2019
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Healncure Products?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Varsha Jain
|
Director | 02-Jul-2019 | Current |
|
Megha Jain
|
Director | 02-Jul-2019 | Current |
Financial Performance of Healncure Products.
Healncure Products Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 210.85% increase. The company also saw a substantial improvement in profitability, with a 53.74% increase in profit. The company's net worth Soared by an impressive increase of 58.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Healncure Products?
Unlock access to Healncure Products's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Hnc Biotech Private LimitedVarsha Jain and Megha Jain are mutual person
-
Adway Print Concept Private Limited
Varsha Jain and Megha Jain are mutual person
Charges (Loans)
₹5.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Jun 2022 | Hdfc Bank Limited | ₹5.00 M | Open |
How Many Employees Work at Healncure Products?
Healncure Products has a workforce of 2 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Healncure Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Healncure Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.